Altogether, these data suggest that a decreased expression of Gal-3 during breast cancer progression might render tumor cells less adherent and more migratory by regulating the expression of tumor GAGs and MMP9, thus increasing the metastatic potential of the tumor. This evidence concerns the gene LGALS3 and breast carcinoma.